文章來(lai)源：上海國資委(wei) 發(fa)布時(shi)間：2013-04-13
3月29日公(gong)布的(de)上海(hai)醫(yi)(yi)藥(yao)2011年(nian)(nian)年(nian)(nian)報(bao)顯示，2011年(nian)(nian)，上海(hai)醫(yi)(yi)藥(yao)實(shi)(shi)現(xian)(xian)(xian)(xian)凈利(li)潤20.42億(yi)元，同(tong)比增(zeng)(zeng)長(chang)40.24%，實(shi)(shi)現(xian)(xian)(xian)(xian)營(ying)業(ye)收入(ru)549億(yi)元，同(tong)比增(zeng)(zeng)長(chang)41.78%。其中，醫(yi)(yi)藥(yao)制造、醫(yi)(yi)藥(yao)分(fen)銷和(he)藥(yao)品零售分(fen)別(bie)實(shi)(shi)現(xian)(xian)(xian)(xian)銷售收入(ru)90.88億(yi)元、465.3億(yi)元和(he)22.77億(yi)元，分(fen)別(bie)同(tong)比增(zeng)(zeng)長(chang)8.47%、57.08%和(he)31.95%。2011年(nian)(nian)，面對不(bu)確定、不(bu)明朗的(de)外(wai)部經濟和(he)醫(yi)(yi)藥(yao)行(xing)(xing)業(ye)環境(jing)(jing)，上海(hai)醫(yi)(yi)藥(yao)抓(zhua)(zhua)住“三條主(zhu)線”，即：抓(zhua)(zhua)經營(ying)，實(shi)(shi)現(xian)(xian)(xian)(xian)產業(ye)持(chi)續發(fa)展(zhan)；抓(zhua)(zhua)融資(zi)，實(shi)(shi)現(xian)(xian)(xian)(xian)H股(gu)成(cheng)功發(fa)行(xing)(xing)；抓(zhua)(zhua)轉型(xing)，實(shi)(shi)現(xian)(xian)(xian)(xian)整合(he)價值(zhi)提升(sheng)。積極推進產業(ye)結構調整，轉變經濟增(zeng)(zeng)長(chang)方式，促進整合(he)，實(shi)(shi)現(xian)(xian)(xian)(xian)價值(zhi)提升(sheng)，同(tong)時通過成(cheng)功完成(cheng)境(jing)(jing)外(wai)上市(shi)，打造了(le)(le)境(jing)(jing)內外(wai)資(zi)本與發(fa)展(zhan)雙(shuang)平(ping)臺，贏得發(fa)展(zhan)資(zi)金，鞏(gong)固了(le)(le)行(xing)(xing)業(ye)地(di)位，實(shi)(shi)現(xian)(xian)(xian)(xian)了(le)(le)地(di)域(yu)、業(ye)務新的(de)拓展(zhan)，初步實(shi)(shi)現(xian)(xian)(xian)(xian)了(le)(le)向全國(guo)性公(gong)司(si)的(de)轉型(xing)，并保(bao)持(chi)了(le)(le)經營(ying)業(ye)績的(de)穩步增(zeng)(zeng)長(chang)。